Search Press releases Keywords From To 17 Sep 2025 BIMZELX[®][▼] (bimekizumab) data in moderate-to-severe plaque psoriasis at EADV showed four-year sustained remission, and potential to reduce psoriatic arthritis progression risk Read More 29 Aug 2025 UCB presents latest research and clinical advancement across leading epilepsy portfolio at International Epilepsy Congress Read More 12 Aug 2025 Transparency notification FMR LLC Read More 31 Jul 2025 From Differentiated Innovation to Outstanding Delivery - A Strong First Half Performance Read More 10 Jul 2025 Transparency notification FMR LLC Read More 8 Jul 2025 Transparency notification BlackRock, Inc. Read More Pagination First page Previous page Previous … Page 7 Page 8 Page 9 Page 10 Current page 11 Page 12 Page 13 Page 14 Page 15 … Page 11 of 67 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
